Hexal is the leading supplier of generic medicines in Germany and is one of Germany's largest pharmaceutical companies. Since 2005, Hexal is part of belonging to Novartis' Sandoz group , the second largest generics manufacturer in the world.
Hexal develops, manufactures and sells high quality generic medicines of the future as well as highly complex.
The portfolio of Hexal covers all major therapeutic areas. It includes non-prescription and prescription generic drug based on 300 active ingredients.
The headquarters of Hexal is in wooden churches in Munich.
Hexal develops, manufactures and markets modern generics and innovative pharmaceuticals complex. As a leading provider of off-patent medicines in Germany Hexal is one of the largest pharmaceutical companies.
Hexal is an important part in ensuring that patients get the medicines in the future they need. We offer cost-effective in all major therapeutic areas, high quality pharmaceuticals.
Quality and innovation are our top priority. We develop our products based on proven drugs targeted to make its application for doctors and patients better and easier, for example, by offering new and improved potency formulations.
Our portfolio includes over 300 active pharmaceutical ingredients. It ranges from drugs with innovative systems for drug delivery to biosimilars , highly complex, bioengineered "drugs of the future". Not for nothing has long Hexal maintains the top position in the development of high-quality generic products.
The integration into an international quality network helps to be his high standards. Hexal is part of the Sandoz Group, one of the world's largest generics manufacturer. In Germany, about 4,300 people are on six sites worked.